Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

A multi-center, dose-escalation study of human type I pancreatic elastase (PRT-201) administered after arteriovenous fistula creation.

Peden EK, Leeser DB, Dixon BS, El-Khatib MT, Roy-Chaudhury P, Lawson JH, Menard MT, Dember LM, Glickman MH, Gustafson PN, Blair AT, Magill M, Franano FN, Burke SK.

J Vasc Access. 2013 Apr-Jun;14(2):143-51. doi: 10.5301/jva.5000125. Epub 2012 Nov 20.

2.

Application of human type I pancreatic elastase (PRT-201) to the venous anastomosis of arteriovenous grafts in patients with chronic kidney disease.

Dwivedi AJ, Roy-Chaudhury P, Peden EK, Browne BJ, Ladenheim ED, Scavo VA, Gustafson PN, Wong MD, Magill M, Lindow F, Blair AT, Jaff MR, Franano FN, Burke SK.

J Vasc Access. 2014 Sep-Oct;15(5):376-84. doi: 10.5301/jva.5000235. Epub 2014 May 3.

3.

Human type I pancreatic elastase treatment of arteriovenous fistulas in patients with chronic kidney disease.

Hye RJ, Peden EK, O'Connor TP, Browne BJ, Dixon BS, Schanzer AS, Jensik SC, Dember LM, Jaff MR, Burke SK.

J Vasc Surg. 2014 Aug;60(2):454-461.e1. doi: 10.1016/j.jvs.2014.02.037. Epub 2014 Mar 27.

4.

Multicenter phase I/II trial of the safety of allogeneic endothelial cell implants after the creation of arteriovenous access for hemodialysis use: the V-HEALTH study.

Conte MS, Nugent HM, Gaccione P, Guleria I, Roy-Chaudhury P, Lawson JH.

J Vasc Surg. 2009 Dec;50(6):1359-68.e1. doi: 10.1016/j.jvs.2009.07.108.

5.

Influence of diabetes and perivascular allogeneic endothelial cell implants on arteriovenous fistula remodeling.

Conte MS, Nugent HM, Gaccione P, Roy-Chaudhury P, Lawson JH.

J Vasc Surg. 2011 Nov;54(5):1383-9. doi: 10.1016/j.jvs.2011.05.005. Epub 2011 Aug 15.

6.

The impact of access blood flow surveillance on reduction of thrombosis in native arteriovenous fistula: a randomized clinical trial.

Aragoncillo I, Amézquita Y, Caldés S, Abad S, Vega A, Cirugeda A, Moratilla C, Ibeas J, Roca-Tey R, Fernández C, Quiroga B, Blanco A, Villaverde M, Ruiz C, Martín B, Ruiz AM, Ampuero J, López-Gómez JM, de Alvaro F.

J Vasc Access. 2016 Jan-Feb;17(1):13-9. doi: 10.5301/jva.5000461. Epub 2015 Sep 18.

PMID:
26391583
7.

Efficiency of the kidney disease outcomes quality initiative guidelines for preemptive vascular access in an academic setting.

Kimball TA, Barz K, Dimond KR, Edwards JM, Nehler MR.

J Vasc Surg. 2011 Sep;54(3):760-5; discussion 765-6. doi: 10.1016/j.jvs.2011.03.006. Epub 2011 Jun 23.

8.

Comparison of the efficacy of upper arm transposed arteriovenous fistulae and upper arm prosthetic grafts.

Woo K, Doros G, Ng T, Farber A.

J Vasc Surg. 2009 Dec;50(6):1405-11.e1-2. doi: 10.1016/j.jvs.2009.07.090. Epub 2009 Sep 26.

9.

Thrombophilia and arteriovenous fistula survival in ESRD.

Salmela B, Hartman J, Peltonen S, Albäck A, Lassila R.

Clin J Am Soc Nephrol. 2013 Jun;8(6):962-8. doi: 10.2215/CJN.03860412. Epub 2013 Feb 14.

10.

A novel technique of vascular anastomosis to prevent juxta-anastomotic stenosis following arteriovenous fistula creation.

Bharat A, Jaenicke M, Shenoy S.

J Vasc Surg. 2012 Jan;55(1):274-80. doi: 10.1016/j.jvs.2011.07.090. Epub 2011 Nov 23.

11.

Primary balloon angioplasty of small (≤2 mm) cephalic veins improves primary patency of arteriovenous fistulae and decreases reintervention rates.

Veroux P, Giaquinta A, Tallarita T, Sinagra N, Virgilio C, Zerbo D, Gloviczki P, Veroux M.

J Vasc Surg. 2013 Jan;57(1):131-6. doi: 10.1016/j.jvs.2012.07.047. Epub 2012 Nov 13.

12.

Heparin bonding does not improve patency of polytetrafluoroethylene arteriovenous grafts.

Allemang MT, Schmotzer B, Wong VL, Chang A, Lakin RO, Woodside KJ, Wang J, Kashyap VS.

Ann Vasc Surg. 2014 Jan;28(1):28-34. doi: 10.1016/j.avsg.2013.08.001. Epub 2013 Nov 5.

PMID:
24200142
13.

Increased minimum vein diameter on preoperative mapping with duplex ultrasound is associated with arteriovenous fistula maturation and secondary patency.

Dageforde LA, Harms KA, Feurer ID, Shaffer D.

J Vasc Surg. 2015 Jan;61(1):170-6. doi: 10.1016/j.jvs.2014.06.092. Epub 2014 Jul 24.

14.

A large-scale study of the upper arm basilic transposition for hemodialysis.

Glass C, Porter J, Singh M, Gillespie D, Young K, Illig K.

Ann Vasc Surg. 2010 Jan;24(1):85-91. doi: 10.1016/j.avsg.2009.05.006. Epub 2009 Jul 23.

PMID:
19631499
15.

Staple aneurysmorrhaphy to salvage autogenous arteriovenous fistulas with aneurysm-related complications.

Vo T, Tumbaga G, Aka P, Behseresht J, Hsu J, Tayarrah M.

J Vasc Surg. 2015 Feb;61(2):457-62. doi: 10.1016/j.jvs.2014.09.008. Epub 2014 Oct 24.

16.

One-year patency rate of native arteriovenous fistulas reconstructed by vascular stripping in hemodialysis patients with venous neointimal hyperplasia.

Lu FP, Liu LP, Lu ZX.

J Vasc Surg. 2015 Jan;61(1):192-6. doi: 10.1016/j.jvs.2014.07.010. Epub 2014 Aug 15.

17.
18.

Multiple preoperative and intraoperative factors predict early fistula thrombosis in the Hemodialysis Fistula Maturation Study.

Farber A, Imrey PB, Huber TS, Kaufman JM, Kraiss LW, Larive B, Li L, Feldman HI; HFM Study Group..

J Vasc Surg. 2016 Jan;63(1):163-70.e6. doi: 10.1016/j.jvs.2015.07.086.

19.

Preventing AVF thrombosis: the rationale and design of the Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study.

Irish A, Dogra G, Mori T, Beller E, Heritier S, Hawley C, Kerr P, Robertson A, Rosman J, Paul-Brent PA, Starfield M, Polkinghorne K, Cass A.

BMC Nephrol. 2009 Jan 21;10:1. doi: 10.1186/1471-2369-10-1.

20.

A systematic review and meta-analysis of systemic intraoperative anticoagulation during arteriovenous access formation for dialysis.

Smith GE, Souroullos P, Cayton T, Harwood A, Carradice D, Chetter IC.

J Vasc Access. 2016 Jan-Feb;17(1):1-5. doi: 10.5301/jva.5000484. Epub 2015 Dec 7. Review.

PMID:
26660043

Supplemental Content

Support Center